These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 10421757)

  • 1. Structural basis for engineering of retinoic acid receptor isotype-selective agonists and antagonists.
    Géhin M; Vivat V; Wurtz JM; Losson R; Chambon P; Moras D; Gronemeyer H
    Chem Biol; 1999 Aug; 6(8):519-29. PubMed ID: 10421757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis for isotype selectivity of the human retinoic acid nuclear receptor.
    Klaholz BP; Mitschler A; Moras D
    J Mol Biol; 2000 Sep; 302(1):155-70. PubMed ID: 10964567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of retinoic acid receptor function alters the growth inhibitory response of oral SCC cells to retinoids.
    Le Q; Dawson MI; Soprano DR; Soprano KJ
    Oncogene; 2000 Mar; 19(11):1457-65. PubMed ID: 10723137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoid receptor subtype-selective modulators through synthetic modifications of RARgamma agonists.
    Alvarez S; Alvarez R; Khanwalkar H; Germain P; Lemaire G; Rodríguez-Barrios F; Gronemeyer H; de Lera AR
    Bioorg Med Chem; 2009 Jul; 17(13):4345-59. PubMed ID: 19482478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C3 halogen and c8'' substituents on stilbene arotinoids modulate retinoic Acid receptor subtype function.
    Alvarez S; Khanwalkar H; Alvarez R; Erb C; Martínez C; Rodríguez-Barrios F; Germain P; Gronemeyer H; de Lera AR
    ChemMedChem; 2009 Oct; 4(10):1630-40. PubMed ID: 19670208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of retinoid receptors in the regulation of mucin gene expression by retinoic acid in human tracheobronchial epithelial cells.
    Koo JS; Jetten AM; Belloni P; Yoon JH; Kim YD; Nettesheim P
    Biochem J; 1999 Mar; 338 ( Pt 2)(Pt 2):351-7. PubMed ID: 10024510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonists of retinoic acid receptors (RARs) are potent growth inhibitors of prostate carcinoma cells.
    Hammond LA; Van Krinks CH; Durham J; Tomkins SE; Burnett RD; Jones EL; Chandraratna RA; Brown G
    Br J Cancer; 2001 Aug; 85(3):453-62. PubMed ID: 11487280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulant effects of synthetic retinoids and activated vitamin D3.
    Koyama T; Hirosawa S
    Semin Thromb Hemost; 1998; 24(3):217-26. PubMed ID: 9701451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Ser(289) in RARgamma and its homologous amino acid residue of RARalpha and RARbeta in the binding of retinoic acid.
    Zhang ZP; Shukri M; Gambone CJ; Gabriel JL; Soprano KJ; Soprano DR
    Arch Biochem Biophys; 2000 Aug; 380(2):339-46. PubMed ID: 10933889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinoic acid receptor beta,gamma-selective ligands: synthesis and biological activity of 6-substituted 2-naphthoic acid retinoids.
    Yu KL; Spinazze P; Ostrowski J; Currier SJ; Pack EJ; Hammer L; Roalsvig T; Honeyman JA; Tortolani DR; Reczek PR; Mansuri MM; Starrett JE
    J Med Chem; 1996 Jun; 39(12):2411-21. PubMed ID: 8691435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells.
    Sun SY; Yue P; Mao L; Dawson MI; Shroot B; Lamph WW; Heyman RA; Chandraratna RA; Shudo K; Hong WK; Lotan R
    Clin Cancer Res; 2000 Apr; 6(4):1563-73. PubMed ID: 10778990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and characterization of retinoic acid receptor beta2 target genes in F9 teratocarcinoma cells.
    Zhuang Y; Faria TN; Chambon P; Gudas LJ
    Mol Cancer Res; 2003 Jun; 1(8):619-30. PubMed ID: 12805409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis.
    Afonja O; Juste D; Das S; Matsuhashi S; Samuels HH
    Oncogene; 2004 Oct; 23(49):8135-45. PubMed ID: 15361828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the differential coregulator binding signatures of the Retinoic Acid Receptor subtypes upon (ant)agonist action.
    Miro Estruch I; Melchers D; Houtman R; de Haan LHJ; Groten JP; Louisse J; Rietjens IMCM
    Biochim Biophys Acta Proteins Proteom; 2017 Sep; 1865(9):1195-1206. PubMed ID: 28642153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a novel class of retinoic acid receptor beta-selective retinoid antagonists and their inhibitory effects on AP-1 activity and retinoic acid-induced apoptosis in human breast cancer cells.
    Li Y; Hashimoto Y; Agadir A; Kagechika H; Zhang Xk
    J Biol Chem; 1999 May; 274(22):15360-6. PubMed ID: 10336422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoic acid receptor alpha mediates growth inhibition by retinoids in human colon carcinoma HT29 cells.
    Nicke B; Kaiser A; Wiedenmann B; Riecken EO; Rosewicz S
    Biochem Biophys Res Commun; 1999 Aug; 261(3):572-7. PubMed ID: 10441468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arginine of retinoic acid receptor beta which coordinates with the carboxyl group of retinoic acid functions independent of the amino acid residues responsible for retinoic acid receptor subtype ligand specificity.
    Zhang ZP; Hutcheson JM; Poynton HC; Gabriel JL; Soprano KJ; Soprano DR
    Arch Biochem Biophys; 2003 Jan; 409(2):375-84. PubMed ID: 12504905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel RARbeta isoform directed by a distinct promoter P3 and mediated by retinoic acid in breast cancer cells.
    Peng X; Maruo T; Cao Y; Punj V; Mehta R; Das Gupta TK; Christov K
    Cancer Res; 2004 Dec; 64(24):8911-8. PubMed ID: 15604252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of selective nuclear receptor modulators: RAR and RXR as a case study.
    de Lera AR; Bourguet W; Altucci L; Gronemeyer H
    Nat Rev Drug Discov; 2007 Oct; 6(10):811-20. PubMed ID: 17906643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptosis induction in cancer cells by a novel analogue of 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalenecarboxylic acid lacking retinoid receptor transcriptional activation activity.
    Dawson MI; Hobbs PD; Peterson VJ; Leid M; Lange CW; Feng KC; Chen Gq ; Gu J; Li H; Kolluri SK; Zhang Xk ; Zhang Y; Fontana JA
    Cancer Res; 2001 Jun; 61(12):4723-30. PubMed ID: 11406543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.